FAMOTIDINE Side Effects

6844010-3 | Polyneuropathy, Porphyria Acute, Quadriplegia
on Jul 06, 2010 Female patient from TUNISIA , 13 years of age, was diagnosed with gastritis, hypertension, grand mal convulsion and was treated with Famotidine (View Usage). Patient experienced the following unwanted or unexpected effects: polyneuropathy, porphyria acute, quadriplegia. Famotidine dosage: Unk. During the same period patient was treated with ADALAT (Unk) (View Adalat Review and Adalat Label ), GARDENAL /00023201/ (Unk) (View Gardenal /00023201/ Review and Gardenal /00023201/ Label ). Patient was hospitalized.

6689919-9 | Hepatitis Acute, Renal Failure Acute
Patient was taking Famotidine (View Usage). Patient had the following side effects: hepatitis acute, renal failure acute on Apr 12, 2010 from UNITED STATES Additional patient health information: Male patient , 47 years of age, . Famotidine dosage: . During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), CEFOXITIN (View Cefoxitin Review and Cefoxitin Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), PROPOFOL (View Propofol Review and Propofol Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ).

6673986-2 | Cardiac Arrest, Poisoning, Respiratory Arrest
Adverse event was reported on Jan 18, 2010 by a Female patient taking Famotidine (View Usage) (Dosage: (df Oral)) . Location: UNITED STATES , 45 years of age, After Famotidine was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), poisoning (What is poisoning?), respiratory arrest. During the same period patient was treated with ETHANOL ((df Oral)) (View Ethanol Review and Ethanol Label ), OXYCODONE HCL ((df Oral)) (View Oxycodone Hcl Review and Oxycodone Hcl Label ), DIAZEPAM ((df Oral)) (View Diazepam Review and Diazepam Label ), LORATADINE ((df Oral)) (View Loratadine Review and Loratadine Label ), CITALOPRAM ((df Oral)) (View Citalopram Review and Citalopram Label ), ATENOLOL ((df Oral)) (View Atenolol Review and Atenolol Label ), LISINOPRIL ((df Oral)) (View Lisinopril Review and Lisinopril Label ), AMITRIPTYLINE (Df Oral) (View Amitriptyline Review and Amitriptyline Label ).

6667073-7 | Product Lot Number Issue, Product Substitution Issue
on Apr 02, 2010 Male patient from UNITED STATES , 69 years of age, weighting 150.4 lb, was diagnosed with dyspepsia and was treated with Famotidine (View Usage). Patient experienced the following unwanted or unexpected effects: product lot number issue, product substitution issue. Famotidine dosage: 20 Mg Once Daily Oral.


6616932-X | Enterocolitis, Gastroenteritis, Haematocrit Decreased, Haemoglobin Decreased, Neutrophil Percentage Decreased, Platelet Count Decreased, Vomiting, White Blood Cell Count Decreased
on Feb 18, 2010 Female patient from JAPAN , 45 years of age, weighting 153.9 lb, was diagnosed with nausea (What is nausea?), breast cancer (What is breast cancer?) and was treated with Famotidine (View Usage). Patient had the following side effects: enterocolitis, gastroenteritis (What is gastroenteritis?), haematocrit decreased, haemoglobin decreased, neutrophil percentage decreased, platelet count decreased, vomiting, white blood cell count decreased. Famotidine dosage: Oral. During the same period patient was treated with SUNITINIB MALATE (37.5 Mg, Once Daily, Oral) (View Sunitinib Malate Review and Sunitinib Malate Label ), PYRIDOXAL PHOSPHATE HYDRATE (View Pyridoxal Phosphate Hydrate Review and Pyridoxal Phosphate Hydrate Label ), UREA (View Urea Review and Urea Label ), SM POWDER (View Sm Powder Review and Sm Powder Label ). Patient was hospitalized.

6549781-1 | Enterocolitis, Gastroenteritis, Haematocrit Decreased, Haemoglobin Decreased, Nausea, Neutrophil Count Decreased, Platelet Count Decreased, White Blood Cell Count Decreased
Patient was taking Famotidine (View Usage). After Famotidine was administered, patient had the following side effects: enterocolitis, gastroenteritis (What is gastroenteritis?), haematocrit decreased, haemoglobin decreased, nausea (What is nausea?), neutrophil count decreased, platelet count decreased, white blood cell count decreased on Jan 04, 2010 from JAPAN Additional patient health information: Female patient , 45 years of age, weighting 153.9 lb, was diagnosed with nausea (What is nausea?), breast cancer (What is breast cancer?) and. Famotidine dosage: Oral. During the same period patient was treated with SUNITINIB MALATE (37.5 Mg, Once Daily, Oral) (View Sunitinib Malate Review and Sunitinib Malate Label ), CAPECITABINE (1750 Mg, Twice Daily, Oral) (View Capecitabine Review and Capecitabine Label ), PYRIDOXAL PHOSPHATE HYDRATE (View Pyridoxal Phosphate Hydrate Review and Pyridoxal Phosphate Hydrate Label ), UREA (View Urea Review and Urea Label ), SM POWDER (View Sm Powder Review and Sm Powder Label ). Patient was hospitalized.

6520018-2 | Hepatitis
Adverse event was reported on Dec 23, 2009 by a Male patient taking Famotidine (View Usage) (Dosage: ) was diagnosed with duodenal ulcer and. Location: KOREA, REPUBLIC OF , 45 years of age, Patient experienced the following unwanted or unexpected effects: hepatitis (What is hepatitis?).

6520017-0 | Hepatitis
on Dec 23, 2009 Female patient from KOREA, REPUBLIC OF , 54 years of age, was diagnosed with gastritis erosive and was treated with Famotidine (View Usage). Patient had the following side effects: hepatitis (What is hepatitis?). Famotidine dosage: . During the same period patient was treated with AZINTAL (View Azintal Review and Azintal Label ), CISAPRIDE (View Cisapride Review and Cisapride Label ). Patient was hospitalized.

6504327-9 | Gastroenteritis
on Dec 08, 2009 Female patient from UNITED STATES , 45 years of age, weighting 153.9 lb, was diagnosed with nausea (What is nausea?), breast cancer (What is breast cancer?) and was treated with Famotidine (View Usage). After Famotidine was administered, patient had the following side effects: gastroenteritis (What is gastroenteritis?). Famotidine dosage: Unk. During the same period patient was treated with SUNITINIB MALATE (25 Mg, Daily) (View Sunitinib Malate Review and Sunitinib Malate Label ), CAPECITABINE (1750 Mg, Bid) (View Capecitabine Review and Capecitabine Label ), PYRIDOXAL PHOSPHATE (Unk) (View Pyridoxal Phosphate Review and Pyridoxal Phosphate Label ), UREA (Unk) (View Urea Review and Urea Label ), GASTROINTESTINAL MEDICINE (SM POWDER) (Unk) (View Gastrointestinal Medicine (sm Powder) Review and Gastrointestinal Medicine (sm Powder) Label ). Patient was hospitalized.

6456252-X | Amnesia, Anaemia, Asthenia, Cerebral Atrophy, Confusional State, Contusion, Dementia, Gait Disturbance, Sinus Tachycardia
Patient was taking Famotidine (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia, anaemia, asthenia, cerebral atrophy, confusional state, contusion, dementia (What is dementia?), gait disturbance, sinus tachycardia on Nov 09, 2009 from UNITED STATES Additional patient health information: Female patient , 72 years of age, . Famotidine dosage: 20 Mg; Qd;. During the same period patient was treated with ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ), ALFALFA SEEDS (View Alfalfa Seeds Review and Alfalfa Seeds Label ), POWDERED GINGER ROOT (View Powdered Ginger Root Review and Powdered Ginger Root Label ), SIBERIAN GINSENG ROOT (View Siberian Ginseng Root Review and Siberian Ginseng Root Label ), KOREAN GINSENG ROOT (View Korean Ginseng Root Review and Korean Ginseng Root Label ), GINKGO BILOBA (View Ginkgo Biloba Review and Ginkgo Biloba Label ), ECHINACEA (View Echinacea Review and Echinacea Label ). Patient was hospitalized.

6432130-7 | Completed Suicide, Condition Aggravated, Constipation, Feeling Abnormal, Gastrointestinal Hypomotility, Malaise, Unresponsive To Stimuli
Adverse event was reported on Oct 27, 2009 by a Female patient taking Famotidine (View Usage) (Dosage: ) . Location: UNITED STATES , 49 years of age, Patient had the following side effects: completed suicide, condition aggravated, constipation (What is constipation?), feeling abnormal, gastrointestinal hypomotility, malaise, unresponsive to stimuli. During the same period patient was treated with HYDROMORPHONE HCL (View Hydromorphone Hcl Review and Hydromorphone Hcl Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), SINGULAIR (View Singulair Review and Singulair Label ), REMERON (View Remeron Review and Remeron Label ), DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ), NEFAZODONE HCL (View Nefazodone Hcl Review and Nefazodone Hcl Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ).

6431139-7 | Hepatitis Cholestatic
on Nov 03, 2009 Male patient from SPAIN , 13 years of age, was diagnosed with abdominal pain upper and was treated with Famotidine (View Usage). After Famotidine was administered, patient had the following side effects: hepatitis cholestatic. Famotidine dosage: . Patient was hospitalized.

6431138-5 | Jaundice Hepatocellular
on Nov 03, 2009 Male patient from UNITED STATES , 55 years of age, was diagnosed with chest discomfort and was treated with Famotidine (View Usage). Patient experienced the following unwanted or unexpected effects: jaundice hepatocellular. Famotidine dosage: . During the same period patient was treated with SUCRALFATE (View Sucralfate Review and Sucralfate Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

6430761-1 | Hepatitis
Patient was taking Famotidine (View Usage). Patient had the following side effects: hepatitis (What is hepatitis?) on Nov 03, 2009 from KOREA, REPUBLIC OF Additional patient health information: Male patient , 45 years of age, was diagnosed with duodenal ulcer and. Famotidine dosage: . Patient was hospitalized.

6430760-X | Hepatitis
Adverse event was reported on Nov 03, 2009 by a Female patient taking Famotidine (View Usage) (Dosage: ) was diagnosed with gastritis erosive and. Location: KOREA, REPUBLIC OF , 54 years of age, After Famotidine was administered, patient had the following side effects: hepatitis (What is hepatitis?).

6430759-3 | Hepatitis
on Nov 03, 2009 Female patient from UNITED STATES , 51 years of age, weighting 205.0 lb, was diagnosed with abdominal pain upper and was treated with Famotidine (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis (What is hepatitis?). Famotidine dosage: . During the same period patient was treated with CONJUGATED ESTROGENS (View Conjugated Estrogens Review and Conjugated Estrogens Label ), MEDROXYPROGESTERONE (View Medroxyprogesterone Review and Medroxyprogesterone Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ).

6428676-8 | Hepatitis Cholestatic
on Nov 03, 2009 Male patient from UNITED STATES , 13 years of age, was diagnosed with abdominal pain upper and was treated with Famotidine (View Usage). Patient had the following side effects: hepatitis cholestatic. Famotidine dosage: . Patient was hospitalized.

6422095-6 | Hepatitis Acute
Patient was taking Famotidine (View Usage). After Famotidine was administered, patient had the following side effects: hepatitis acute on Oct 27, 2009 from UNITED STATES Additional patient health information: Male patient , 47 years of age, . Famotidine dosage: . During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), CEFOXITIN (View Cefoxitin Review and Cefoxitin Label ). Patient was hospitalized.

6415068-0 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Bilirubin Increased, International Normalised Ratio Increased
Adverse event was reported on Oct 07, 2009 by a Male patient taking Famotidine (View Usage) (Dosage: ) . Location: UNITED STATES , 47 years of age, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, international normalised ratio increased. During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), CEFOXITIN (View Cefoxitin Review and Cefoxitin Label ), FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ), PROPOFOL (View Propofol Review and Propofol Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ). Patient was hospitalized.

6412731-2 | Long Qt Syndrome, Torsade De Pointes
on Oct 20, 2009 Male patient from UNITED STATES , 92 years of age, was diagnosed with international normalised ratio increased and was treated with Famotidine (View Usage). Patient had the following side effects: long qt syndrome, torsade de pointes. Famotidine dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), HEPARIN (View Heparin Review and Heparin Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), VITAMIN K TAB (View Vitamin K Tab Review and Vitamin K Tab Label ), INSULIN (View Insulin Review and Insulin Label ).

6383198-8 | Alopecia
on Sep 14, 2009 Female patient from UNITED STATES , 80 years of age, weighting 112.0 lb, was diagnosed with gastrooesophageal reflux disease and was treated with Famotidine (View Usage). After Famotidine was administered, patient had the following side effects: alopecia. Famotidine dosage: 20mg B.i.d..

6368680-1 | Abnormal Behaviour, Anxiety, Dyspepsia, Feeling Abnormal, Feeling Hot, Headache, Hyperhidrosis
Patient was taking Famotidine (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, anxiety (What is anxiety?), dyspepsia, feeling abnormal, feeling hot, headache (What is headache?), hyperhidrosis on Sep 17, 2009 from UNITED STATES Additional patient health information: Female patient , 51 years of age, weighting 276.0 lb, was diagnosed with gastrooesophageal reflux disease, ulcer (What is ulcer?) and. Famotidine dosage: One Tablet At Bedtime Po.

6342203-5 | Confusional State, Hallucination
Adverse event was reported on Sep 03, 2009 by a Male patient taking Famotidine (View Usage) (Dosage: 20mg Bid Iv) was diagnosed with prophylaxis, stress (What is stress?) and. Location: UNITED STATES , 68 years of age, weighting 174.8 lb, Patient had the following side effects: confusional state, hallucination.

6332386-5 | Crohn's Disease
on Aug 18, 2009 Male patient from JAPAN , 18 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Famotidine (View Usage). After Famotidine was administered, patient had the following side effects: crohn's disease (What is crohn's disease?). Famotidine dosage: . During the same period patient was treated with MESALAZINE (View Mesalazine Review and Mesalazine Label ). Patient was hospitalized.

6276408-9 | Jaundice
on Jul 17, 2009 Female patient from UNITED STATES , 27 years of age, weighting 145.0 lb, was diagnosed with duodenal ulcer and was treated with Famotidine (View Usage). Patient experienced the following unwanted or unexpected effects: jaundice (What is jaundice?). Famotidine dosage: 1 Pill Twice Daily Po.

6255686-6 | Headache, Malaise, Rectal Discharge, Rectal Haemorrhage
Patient was taking Famotidine (View Usage). Patient had the following side effects: headache (What is headache?), malaise, rectal discharge, rectal haemorrhage on Jun 22, 2009 from UNITED STATES Additional patient health information: Female patient , 68 years of age, . Famotidine dosage: Oral.

6211856-4 | Herpes Zoster
Adverse event was reported on May 13, 2009 by a Female patient taking Famotidine (View Usage) (Dosage: 20 Mg/daily Po) was diagnosed with gastritis erosive and. Location: JAPAN , 66 years of age, After Famotidine was administered, patient had the following side effects: herpes zoster. During the same period patient was treated with GRAN TROXSIN (TROXIPIDE) (1 Gm/daily Po) (View Gran Troxsin (troxipide) Review and Gran Troxsin (troxipide) Label ). Patient was hospitalized.

6164445-4 | Abdominal Discomfort, Abdominal Pain Upper, Anaemia Vitamin B12 Deficiency, Asthenia, Blood Albumin Decreased, Cerebral Atrophy, Confusional State, Delirium, Dementia
on Apr 09, 2009 Female patient from UNITED STATES , 72 years of age, was treated with Famotidine (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal discomfort, abdominal pain upper, anaemia vitamin b12 deficiency, asthenia, blood albumin decreased, cerebral atrophy, confusional state, delirium, dementia (What is dementia?). Famotidine dosage: 20 Mg;. During the same period patient was treated with ESOMEPRAZOLE (40 Mg;) (View Esomeprazole Review and Esomeprazole Label ), HERBAL PREPARATION (View Herbal Preparation Review and Herbal Preparation Label ). Patient was hospitalized.

6159989-5 | Abdominal Discomfort, Amnesia, Anaemia, Asthenia, Blood Albumin Decreased, Brain Scan Abnormal, Confusional State, Decreased Appetite, Delirium
on Apr 09, 2009 Female patient from UNITED STATES , 72 years of age, was diagnosed with peptic ulcer (What is peptic ulcer?) and was treated with Famotidine (View Usage). Patient had the following side effects: abdominal discomfort, amnesia, anaemia, asthenia, blood albumin decreased, brain scan abnormal, confusional state, decreased appetite, delirium. Famotidine dosage: Chronic Use, Oral. During the same period patient was treated with ESOMEPRAZOLE MAGNESIUM (Chronic Use Oral) (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), ALFALFA SEEDS (MEDICAGO SATIVA) (View Alfalfa Seeds (medicago Sativa) Review and Alfalfa Seeds (medicago Sativa) Label ), GINGER (ZINGIBER OFFICINALE RHIZOME (Oral) (View Ginger (zingiber Officinale Rhizome Review and Ginger (zingiber Officinale Rhizome Label ), GINSENG (PANAX GINSENG ROOT) (Oral) (View Ginseng (panax Ginseng Root) Review and Ginseng (panax Ginseng Root) Label ), HERBAL PREPARATION () (View Herbal Preparation () Review and Herbal Preparation () Label ). Patient was hospitalized.

6149004-1 | Abdominal Discomfort, Amnesia, Anaemia, Anorexia, Blood Albumin Decreased, Cerebral Atrophy, Confusional State, Delirium, Dementia
Patient was taking Famotidine (View Usage). After Famotidine was administered, patient had the following side effects: abdominal discomfort, amnesia, anaemia, anorexia, blood albumin decreased, cerebral atrophy, confusional state, delirium, dementia (What is dementia?) on Mar 26, 2009 from UNITED STATES Additional patient health information: Female patient , 72 years of age, . Famotidine dosage: 20 Mg. During the same period patient was treated with ECHINACEA PUPUREA (NGX)(ECHINACEA PURPUREA) (View Echinacea Pupurea (ngx)(echinacea Purpurea) Review and Echinacea Pupurea (ngx)(echinacea Purpurea) Label ), GINKGO BILOBA (NGX)(GINKGO BILOBA) (View Ginkgo Biloba (ngx)(ginkgo Biloba) Review and Ginkgo Biloba (ngx)(ginkgo Biloba) Label ), ESOMEPRAZOLE MAGNESIUM (40 Mg) (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), ALFALFA (MEDICAGO SATIVA) (View Alfalfa (medicago Sativa) Review and Alfalfa (medicago Sativa) Label ), SIBERIAN GINSENG (ELEUTHEROCOCCUS SENTICOSUS, RUSSIAN GINSENG) (View Siberian Ginseng (eleutherococcus Senticosus, Russian Ginseng) Review and Siberian Ginseng (eleutherococcus Senticosus, Russian Ginseng) Label ), KOREAN GINSENG (KOREAN GINSENG, PANAX GINSENG) (View Korean Ginseng (korean Ginseng, Panax Ginseng) Review and Korean Ginseng (korean Ginseng, Panax Ginseng) Label ), GINGER (ZINGIBER OFFICINALE RHIZOME) (View Ginger (zingiber Officinale Rhizome) Review and Ginger (zingiber Officinale Rhizome) Label ). Patient was hospitalized.

6136838-2 | Hepatitis, International Normalised Ratio Increased
Adverse event was reported on Feb 16, 2009 by a Male patient taking Famotidine (View Usage) (Dosage: ) was diagnosed with cholecystitis acute and. Location: UNITED STATES , 47 years of age, Patient experienced the following unwanted or unexpected effects: hepatitis (What is hepatitis?), international normalised ratio increased. During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), CEFOXITIN (View Cefoxitin Review and Cefoxitin Label ), FENTANYL 25 (View Fentanyl-25 Review and Fentanyl-25 Label ), PROPOFOL (View Propofol Review and Propofol Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ). Patient was hospitalized.

6130556-2 | Cholecystitis Acute, Cholelithiasis, Hepatitis Acute
on Mar 10, 2009 Male patient from UNITED STATES , 47 years of age, was diagnosed with prophylaxis and was treated with Famotidine (View Usage). Patient had the following side effects: cholecystitis acute, cholelithiasis, hepatitis acute. Famotidine dosage: Oral. During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), CEFOXITIN (CEFOXITIN) (View Cefoxitin (cefoxitin) Review and Cefoxitin (cefoxitin) Label ), FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ), PROPOFOL (View Propofol Review and Propofol Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ). Patient was hospitalized.

6107246-5 | Abdominal Pain, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Bilirubin Increased, International Normalised Ratio Increased, Urine Colour Abnormal
on Feb 17, 2009 Male patient from UNITED STATES , 47 years of age, was treated with Famotidine (View Usage). After Famotidine was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, international normalised ratio increased, urine colour abnormal. Famotidine dosage: . During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), CEFOXITIN (View Cefoxitin Review and Cefoxitin Label ), FENTANYL 25 (View Fentanyl-25 Review and Fentanyl-25 Label ), PROPOFOL (View Propofol Review and Propofol Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ).

6105282-6 | Abdominal Pain, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Bilirubin Increased, International Normalised Ratio Increased, Urine Colour Abnormal
Patient was taking Famotidine (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, international normalised ratio increased, urine colour abnormal on Feb 17, 2009 from UNITED STATES Additional patient health information: Male patient , 47 years of age, . Famotidine dosage: . During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), CEFOXITIN (View Cefoxitin Review and Cefoxitin Label ), FENTANYL 25 (View Fentanyl-25 Review and Fentanyl-25 Label ), PROPOFOL (View Propofol Review and Propofol Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ).

6104659-2 | Hepatitis Acute, Renal Impairment
Adverse event was reported on Feb 16, 2009 by a Male patient taking Famotidine (View Usage) (Dosage: Oral) was diagnosed with cholecystitis acute and. Location: UNITED STATES , 47 years of age, Patient had the following side effects: hepatitis acute, renal impairment. During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), CEFOXITIN (View Cefoxitin Review and Cefoxitin Label ). Patient was hospitalized.

6093817-1 | Electrocardiogram Qt Prolonged
on Feb 18, 2009 Female patient from JAPAN , 85 years of age, was diagnosed with oedema peripheral and was treated with Famotidine (View Usage). After Famotidine was administered, patient had the following side effects: electrocardiogram qt prolonged. Famotidine dosage: 10 Mg, Bid. During the same period patient was treated with MOXIFLOXACIN HCL (400 Mg, Qd) (View Moxifloxacin Hcl Review and Moxifloxacin Hcl Label ). Patient was hospitalized.

6091242-0 | Blood Pressure Increased, Constipation, Gastrointestinal Pain, No Therapeutic Response, Pancreatitis Acute
on Feb 20, 2009 Female patient from UNITED STATES , 68 years of age, weighting 136.0 lb, was diagnosed with dyspepsia and was treated with Famotidine (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased, constipation (What is constipation?), gastrointestinal pain, no therapeutic response, pancreatitis acute. Famotidine dosage: 1 Tablet Twice Daily Po. During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), SALINE DRIP (View Saline Drip Review and Saline Drip Label ), ANTI CLOTTING INSTRUMUSCULAR INJECTION (View Anti-clotting Instrumuscular Injection Review and Anti-clotting Instrumuscular Injection Label ), HYDROCODONE BITARTRATE + ACETAMINOPHEN (View Hydrocodone Bitartrate + Acetaminophen Review and Hydrocodone Bitartrate + Acetaminophen Label ).

6090175-3 | Hepatitis Acute, Renal Impairment, Renal Injury
Patient was taking Famotidine (View Usage). Patient had the following side effects: hepatitis acute, renal impairment, renal injury on Feb 10, 2009 from UNITED STATES Additional patient health information: Male patient , 47 years of age, . Famotidine dosage: . During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), CEFOXITIN (CEFOXITIN) (View Cefoxitin (cefoxitin) Review and Cefoxitin (cefoxitin) Label ), FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ), PROPOFOL (View Propofol Review and Propofol Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ). Patient was hospitalized.

6071643-7 | Agitation, Blood Pressure Increased, Blood Pressure Systolic Increased, Nervousness
Adverse event was reported on Feb 09, 2009 by a Female patient taking Famotidine (View Usage) (Dosage: 20 Mg - 955 1 Tab Twice Dly Tab. Very Infrequently Because Of The Effect Described) was diagnosed with gastrooesophageal reflux disease and. Location: UNITED STATES , weighting 180.0 lb, After Famotidine was administered, patient had the following side effects: agitation, blood pressure increased, blood pressure systolic increased, nervousness.

6043665-3 | Bradycardia, Electrocardiogram Qt Prolonged
on Jan 05, 2009 Female patient from JAPAN , 85 years of age, weighting 77.16 lb, was diagnosed with cellulitis (What is cellulitis?) and was treated with Famotidine (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, electrocardiogram qt prolonged. Famotidine dosage: 10 Mg, Bid;. During the same period patient was treated with MOXIFLOXACIN HCL (400 Mg, Daily; Oral) (View Moxifloxacin Hcl Review and Moxifloxacin Hcl Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ). Patient was hospitalized.

6030346-5 | Gout
on Jan 06, 2009 Male patient from UNITED STATES , 40 years of age, weighting 161.2 lb, was diagnosed with prophylaxis against gastrointestinal ulcer and was treated with Famotidine (View Usage). Patient had the following side effects: gout (What is gout?). Famotidine dosage: 20 Mg Bid Po. Patient was hospitalized.

5989039-2 | Gastrooesophageal Reflux Disease, Insomnia, Product Contamination, Product Quality Issue
Patient was taking Famotidine (View Usage). After Famotidine was administered, patient had the following side effects: gastrooesophageal reflux disease, insomnia, product contamination, product quality issue on Dec 09, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 210.0 lb, was diagnosed with gastrooesophageal reflux disease and. Famotidine dosage: 20 Mg Tablet Twice A Day Po.

5963865-8 | Rhabdomyolysis
Adverse event was reported on Nov 12, 2008 by a Male patient taking Famotidine (View Usage) (Dosage: Unk) was diagnosed with myocardial infarction, percutaneous coronary intervention and. Location: JAPAN , 58 years of age, Patient experienced the following unwanted or unexpected effects: rhabdomyolysis. During the same period patient was treated with MIDAZOLAM HCL (Unk) (View Midazolam Hcl Review and Midazolam Hcl Label ), WARFARIN POTASSIUM (Unk) (View Warfarin Potassium Review and Warfarin Potassium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ).

5940718-2 | Thrombocytopenia
on Nov 03, 2008 Male patient from UNITED STATES , 86 years of age, was diagnosed with gastrointestinal disorder, prophylaxis, pneumonia (What is pneumonia?) and was treated with Famotidine (View Usage). Patient had the following side effects: thrombocytopenia. Famotidine dosage: 20 Mg Bid Iv. During the same period patient was treated with PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM (2.25 Gm Qid Iv) (View Piperacillin Sodium And Tazobactam Sodium Review and Piperacillin Sodium And Tazobactam Sodium Label ). Patient was hospitalized.

5930961-0 | Anorexia, Confusional State, Dehydration, Delirium, Disorientation, Hallucination, Visual, Malignant Neoplasm Progression, Prostate Cancer Metastatic
on Oct 08, 2008 Male patient from JAPAN , 68 years of age, was treated with Famotidine (View Usage). After Famotidine was administered, patient had the following side effects: anorexia, confusional state, dehydration, delirium, disorientation, hallucination, visual, malignant neoplasm progression, prostate cancer metastatic. Famotidine dosage: 40 Mg; Daily,. During the same period patient was treated with . (View . Review and . Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ), CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ).

5930364-9 | Anorexia, Confusional State, Dehydration, Disorientation, Hallucination, Visual, Malignant Neoplasm Progression
Patient was taking Famotidine (View Usage). Patient experienced the following unwanted or unexpected effects: anorexia, confusional state, dehydration, disorientation, hallucination, visual, malignant neoplasm progression on Oct 08, 2008 from JAPAN Additional patient health information: Male patient , 68 years of age, . Famotidine dosage: 40 Mg;daily. During the same period patient was treated with OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ).

5914535-3 | Alanine Aminotransferase Increased, Alopecia, Aspartate Aminotransferase Increased, Blood Creatine Phosphokinase Increased, Blood Pressure Decreased, Bone Marrow Failure, Diarrhoea, Pneumonia
Adverse event was reported on Sep 22, 2008 by a Female patient taking Famotidine (View Usage) (Dosage: ) . Location: TURKEY , 26 years of age, Patient had the following side effects: alanine aminotransferase increased, alopecia, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood pressure decreased, bone marrow failure, diarrhoea, pneumonia (What is pneumonia?). During the same period patient was treated with COLCHICINE (Oral) (View Colchicine Review and Colchicine Label ), ACETAMINOPHEN (Oral) (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

5899382-3 | Abdominal Tenderness, Alanine Aminotransferase Increased, Alopecia, Aspartate Aminotransferase Increased, Blood Creatine Phosphokinase Increased, Blood Lactate Dehydrogenase Increased, Blood Sodium Decreased, Diarrhoea, Haemoglobin Decreased
on Sep 02, 2008 Female patient from UNITED STATES , 26 years of age, was treated with Famotidine (View Usage). After Famotidine was administered, patient had the following side effects: abdominal tenderness, alanine aminotransferase increased, alopecia, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, blood sodium decreased, diarrhoea, haemoglobin decreased. Famotidine dosage: . During the same period patient was treated with COLCHICINE (, Oral) (View Colchicine Review and Colchicine Label ), ACETAMINOPHEN (, Oral) (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

5877713-8 | Abdominal Tenderness, Alanine Aminotransferase Increased, Alopecia, Aspartate Aminotransferase Increased, Blood Creatine Phosphokinase Increased, Blood Lactate Dehydrogenase Increased, Diarrhoea, Gamma-glutamyltransferase Increased
on Sep 05, 2008 Female patient from TURKEY , 26 years of age, was treated with Famotidine (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal tenderness, alanine aminotransferase increased, alopecia, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, diarrhoea, gamma-glutamyltransferase increased. Famotidine dosage: . During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), COLCHICINE (View Colchicine Review and Colchicine Label ). Patient was hospitalized.

5834760-X | Deep Vein Thrombosis, Neoplasm Progression
Patient was taking Famotidine (View Usage). Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), neoplasm progression on Jul 29, 2008 from HUNGARY Additional patient health information: Female patient , 65 years of age, was diagnosed with colorectal cancer (What is colorectal cancer?) and. Famotidine dosage: 40 Mg, Qd. During the same period patient was treated with PANITUMUMAB (PANITUMUMAB) (432 Mg, Intravenous) (View Panitumumab (panitumumab) Review and Panitumumab (panitumumab) Label ). Patient was hospitalized.